ARS Pharmaceuticals (SPRY) Return on Assets [ROA] (2021 - 2026)
ARS Pharmaceuticals (SPRY) posted Return on Assets [ROA] of -80.54% for Q2 2026, down 62.01 percentage points from -18.52% a year earlier and down 14.73 percentage points from the prior quarter.
Powered by 
Analysis
ARS Pharmaceuticals (SPRY) Return on Assets [ROA] (2021 - 2026) Analysis & Trends
For FY2025, ARS Pharmaceuticals' Return on Assets [ROA] came in at -50.47%, down 53.21 percentage points from FY2024.
- Annual Return on Assets [ROA] shows a four-year change of -41.94 percentage points (FY2021 to FY2025).
- In prior years, ARS Pharmaceuticals' Return on Assets [ROA] was 2.74% in FY2024 (+23.87 pp), -21.13% in FY2023 (-0.41 pp), -20.72% in FY2022 (-12.19 pp) and -8.53% in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Return on Assets [ROA] in data going back to Q1 2021.
- On a year-over-year basis, Return on Assets [ROA] has declined in each of the last three quarters, with an average year-over-year change of -14.40 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q3 2022, with a gain of 31.41 percentage points; the weakest was Q2 2026, with a drop of 62.01 percentage points.
- According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -65.80% (Q1 2026), -51.24% (Q4 2025) and -26.46% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | ARS Pharmaceuticals | 428.58 Mn | 284.78 Mn | 20.81 Mn | -80.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -80.54% |
| Mar 31, 2026 | -65.80% |
| Dec 31, 2025 | -51.24% |
| Sep 30, 2025 | -26.46% |
| Jun 30, 2025 | -18.52% |
| Mar 31, 2025 | -7.98% |
| Dec 31, 2024 | -1.08% |
| Sep 30, 2024 | -27.53% |
| Jun 30, 2024 | -25.24% |
| Mar 31, 2024 | -26.91% |
| Dec 31, 2023 | -28.03% |
| Sep 30, 2023 | -28.68% |
| Jun 30, 2023 | -23.17% |
| Mar 31, 2023 | -17.06% |
| Dec 31, 2022 | -12.86% |
| Sep 30, 2022 | 9.40% |
| Jun 30, 2022 | 3.46% |
| Mar 31, 2022 | -4.10% |
| Dec 31, 2021 | -9.40% |
| Sep 30, 2021 | -22.01% |
API Access
ARS Pharmaceuticals Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SPRY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();